Skip to main content

March 2024 ADLM SoCal Local Section Presents: Advancements in Traumatic Brain Assessment and Point of Care Connectivity...

Tracking # 20-1184710

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Seminar
Dates Contact provider

Course overview

Advancements in Traumatic Brain Assessment Traumatic brain injury (TBI) occurs when a sudden, external, physical assault damages the brain. TBI, a broad term describing a vast array of injuries that happen to the brain, can be confined to one area of the brain or diffuse, occurring to more than one area of the brain. The severity of TBI may range from mild concussions affecting brain cells temporarily to more severe TBI resulting in bruising, torn tissues, bleeding, and other physical damage to the brain. These injuries can result in long-term complications, coma, or even death. Because the causes of TBI are part of everyday life, there is a need to bring awareness to TBI, especially to the at-risk patient population. This in-person presentation will define TBI, present the current guidelines and recommendations in clinical practice, and the new methods that advance the assessment of brain health. Point of Care Connectivity and The Importance of Post-Analytic Efficiency Point-of-Care Testing (POCT), clinical laboratory testing conducted close to the site of patient care, provides rapid turnaround of test results. With the potential to generate a quick result, the appropriate treatment can be implemented quicker potentially leading to improved clinical or economic outcomes. POCT and POCT result data has grown tremendously and there is a need to learn how to effectively manage this data for effective patient care. This in-person presentation describes how POC connectivity platforms enable the utilization of post-analytical processes, similar to well-established post-analytical processes used in the clinical laboratory, and how this leads to reporting accurate and timely results and enhancing post-analytical efficiencies.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

2h Category 1

Molecular Diagnostics Diplomate

2h Category 1

Toxicological Chemistry Diplomate

2h Category 1

Disclosure statements

ADLM is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following planners and faculty reported relevant financial relationship(s):

  • Leslie Saxon, MD
  • Abbott Diagnostics; Grant/Research Support, Consultant Fee, Honorarium/Expenses
  • Omai Garner, PhD, D(ABMM)
  • Biomerieux, Grant/Research Support
  • Diasorin, Grant/Research Support
  • Beckman Coulter, Grant/Research Support
  • SeeGene, Board/Committee Membership/Advisory Board
  • Roche, Honorarium/Expenses